Overview

STudy of Atropine Therapeutic Effect on Myopic Progression

Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
This study is to evaluate the therapeutic effect and safety of LPTAT in children with myopia.
Phase:
Phase 3
Details
Lead Sponsor:
LitePharmTech Co., Ltd.
Treatments:
Atropine